4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001104659-21-063814
Options or other derivatives
- Chief Financial Officer acquired 35,653 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fatal Sigal · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-07 | Grant or award : show line 1 in the form Option to Purchase American Depositary Shares | +35,653 | 35,653 | D |
Loading xslF345X03/tm2115776-1_4seq1.xml…